Wolverine Trading’s BIO-key International BKYI Stock Holding History

Wolverine Trading’s Portfolio BKYI Stock Details BKYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-86	Closed	-$38K	–	4524
2022 Q1	$38K	Buy	86 +20	+30%	+$8.08K	﹤0.01%	5143
2021 Q4	$26K	Buy	+66	New	+$33.3K	﹤0.01%	5472
2021 Q3	–	Sell	-70	Closed	-$41.3K	–	6261
2021 Q2	$48K	Buy	+70	New	+$46K	﹤0.01%	5607

Other funds holding BKYI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Wolverine Trading's BKYI Position: Q2 2022 in Review

Wolverine Trading sold out of BIO-key International (BKYI) in Q2 2022, closing a stake of 86 shares — an estimated $38K sold.

Wolverine Trading first reported a position in BKYI in Q2 2021 and held it in 3 quarters. The position peaked at $48K in Q2 2021. 8 funds tracked by Wall St. Rank hold BKYI as of Q2 2022.

Wolverine Trading reported no remaining BIO-key International position as of Q2 2022 after selling out during the quarter.
Wolverine Trading sold 86 BIO-key International shares in Q2 2022, an estimated $38K.
Wolverine Trading first reported a position in BIO-key International in Q2 2021 and held it in 3 quarters.
Wolverine Trading's BIO-key International position peaked at $48K in Q2 2021.
8 funds tracked by Wall St. Rank held BIO-key International as of Q2 2022.

Based on Wolverine Trading's 13F filing for Q2 2022, filed 15 Aug 2022.